A comparison analysis of the use of intravenous β-interferon-1a 30 mcg and subcutaneous β-interferon-1a 44 mcg in routine clinical practice of treatment in patients with multiple sclerosis

Authors:

Abstract
To compare the results of treatment of multiple sclerosis (MS) with genfaxon, cinnovex and rebif.